Research Topics
| A L StollSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trialA L Stoll
Brigham and Women s Hospital, Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
Arch Gen Psychiatry 56:407-12. 1999..The present study was performed to examine whether omega3 fatty acids also exhibit mood-stabilizing properties in bipolar disorder...- Gait unsteadiness and fall risk in two affective disorders: a preliminary studyJeffrey M Hausdorff
Division on Aging, Harvard Medical School, Boston, MA, USA
BMC Psychiatry 4:39. 2004.... - Mood stabilizer combinations: a review of safety and efficacyM P Freeman
Psychopharmacology Unit, Division of Psychiatry, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Psychiatry 155:12-21. 1998..Polypharmacy is common in the treatment of refractory bipolar disorder. The purpose of this article is to review the safety and efficacy of mood stabilizers in combinations... - Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortexC M Moore
Brain Imaging Center, McLean Hospital, Belmont, MA, USA
Bipolar Disord 2:207-16. 2000..We wished to determine the relationship between anterior cingulate cortex choline and myo-inositol levels, assessed using proton magnetic resonance spectroscopic imaging (MRSI), and mood state in subjects with bipolar disorder... - Psychiatric agriculture: systemic nutritional modification and mental health in the developing worldDouglas S London
Psychopharmacological Research Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA
Med Hypotheses 66:1234-9. 2006.... - Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in ratsWilliam A Carlezon
Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
Biol Psychiatry 57:343-50. 2005..We also examined the effects of omega-3 fatty acids (OMG), which increase membrane fluidity and reportedly have antidepressant effects in humans, alone and in combination with uridine... - Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patientsJ Eric Jensen
Brain Imaging Center, McLean Hospital, Belmont, Massachusetts 02478 9106, USA
Exp Clin Psychopharmacol 16:199-206. 2008..These results suggest that TAU treatment may decrease symptoms of depression and improve mitochondrial functioning... - Low-field magnetic stimulation in bipolar depression using an MRI-based stimulatorMichael Rohan
Brain Imaging Center, McLean Hospital, Belmont, MA 02478, USA
Am J Psychiatry 161:93-8. 2004..This study evaluated possible mood improvement associated with this procedure... - S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjectsMarisa M Silveri
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Biol Psychiatry 54:833-9. 2003..These findings suggest that S-adenosyl-L-methionine alters parameters associated with cerebral bioenergetic status and that some effects of S-adenosyl-L-methionine (T2RT) occur in a gender-specific manner... - How blind is double-blind? A study of fish oil versus placeboKaren E Damico
Psychopharmacology Research Laboratory, Center for the Development of Novel and Natural Treatments for Mood Disorders, McLean Hospital, Belmont, MA 02478, USA
Prostaglandins Leukot Essent Fatty Acids 66:393-5. 2002..The results suggest that altering subjects' expectations could further improve the validity of the double-blind... - Omega-3 fatty acids: evidence basis for treatment and future research in psychiatryMarlene P Freeman
Women s Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson 85724 5002, USA
J Clin Psychiatry 67:1954-67. 2006..To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders... - Brain metabolic alterations in medication-free patients with bipolar disorderStephen R Dager
Department of Radiology, University of Washington, Seattle 98105, USA
Arch Gen Psychiatry 61:450-8. 2004..Bipolar disorder (BD) has substantial morbidity and incompletely understood neurobiological underpinnings... - Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorderFuyuki Hirashima
Brain Imaging Center, McLean Hospital, Belmont, MA, USA
Am J Psychiatry 161:1922-4. 2004..The authors hypothesized that changes in brain membrane composition resulting from omega-3 fatty acid administration in patients with bipolar disorder would result in greater membrane fluidity, as detected by reductions in T(2) values... - Lithium and valproic acid treatment effects on brain chemistry in bipolar disorderSeth D Friedman
Department of Radiology, University of Washington, Seattle, Washington, USA
Biol Psychiatry 56:340-8. 2004..This study examined whether lithium (Li) and valproic acid (VPA) treatment modulated these chemicals... - Frontal lobe gray matter density decreases in bipolar I disorderIn Kyoon Lyoo
Brain Imaging Center, McLean Hospital, Belmont, Massachusetts 02478, USA
Biol Psychiatry 55:648-51. 2004..Decreased gray matter density in the right inferior frontal gyrus, which processes nonverbal and intrinsic functions, supports nondominant hemisphere dysfunction as a component of bipolar disorder... - Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humansJessica L Goren
Psychopharmacology Research Laboratory, Program for the Development of Natural and Novel Treatments for Bipolar Disorder, McLean Hospital, Belmont, Massachusetts
Pharmacotherapy 24:1501-7. 2004..Serum homocysteine levels were also measured since alterations in these levels have been theorized in association with SAMe...